NEWSON HEALTH LIMITED
Get an alert when NEWSON HEALTH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-19 (in 7mo)
Last made up 2025-12-05
Watchouts
None on the register
Cash
£1M
+473.8% vs 2023
Net assets
£1M
+381.5% vs 2023
Employees
168
-16.8% vs 2023
Profit before tax
£1M
+183.9% first positive since 2023
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £14,254,274 | £13,802,606 | |
| Operating profit | — | — | — | — | -£345,519 | £933,161 | |
| Profit before tax | — | — | — | £2,320,384 | -£1,250,764 | £1,048,966 | |
| Net profit | — | — | — | £1,891,463 | -£1,131,240 | £819,260 | |
| Cash | £203,599 | £359,192 | £569,990 | £1,479,474 | £237,716 | £1,363,899 | |
| Total assets less current liabilities | £133,172 | £424,375 | £886,270 | £1,912,002 | £209,823 | £1,049,539 | |
| Net assets | £98,417 | £400,820 | £854,396 | £1,851,063 | £209,823 | £1,010,333 | |
| Equity | £98,417 | £400,820 | £854,396 | £1,851,063 | £209,823 | £1,010,333 | |
| Average employees | — | — | — | 159 | 202 | 168 | |
| Wages | — | — | — | — | £8,690,901 | £7,574,404 | |
| Directors' remuneration | — | — | — | £486,364 | £515,145 | £514,663 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-3.2%
£14,254,274 £13,802,606
-
Cash
+473.8%
£237,716 £1,363,899
-
Net assets
+381.5%
£209,823 £1,010,333
-
Employees
-16.8%
202 168
-
Operating profit
+370.1%
-£345,519 £933,161
-
Profit before tax
+183.9%
-£1,250,764 £1,048,966
first positive since 2023
-
Wages
-12.8%
£8,690,901 £7,574,404
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -2.4% | 6.8% | |
| Net margin | — | — | — | — | -7.9% | 5.9% | |
| Return on capital employed | — | — | — | — | -164.7% | 88.9% | |
| Current ratio | — | — | — | — | 0.77x | 1.41x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- NEWSON HEALTH LIMITED 2018-02-23 → present
- THE MENOPAUSE CLINIC LIMITED 2017-12-12 → 2018-02-23
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ormerod Rutter Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “The operating profit for 2024 of £933k overturns the loss reported in 2023 of £(346k), due to the restructure of business late 2023, early 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ANDERSON, Louise Rachel, Dr | Director | 2017-12-12 | Aug 1970 | British |
| DALY, Marcus Hugh Paul | Director | 2019-01-02 | Jul 1957 | British |
| LEWIS, Rebecca Jane, Dr | Director | 2018-09-01 | Oct 1967 | British |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GREEN, Rebecca Ann | Secretary | 2024-04-16 | 2025-02-07 |
| PALMER, Katrina Laura | Secretary | 2019-01-02 | 2024-04-16 |
| CROWFOOT, Jill, Dr | Director | 2018-09-01 | 2018-12-15 |
| CROWFOOT, Martyn Christopher | Director | 2018-09-01 | 2018-12-15 |
| DARBY, Alistair William | Director | 2021-11-05 | 2023-02-01 |
| GREEN, Rebecca Ann | Director | 2024-04-16 | 2024-04-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Newson Health Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-12-31 | Active |
| Newson Health Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-04-06 | Ceased 2022-12-31 |
| Dr Paul Craig Bull Anderson | Individual | Shares 25–50%, Voting 25–50% | 2019-12-18 | Ceased 2020-04-06 |
| Dr Louise Rachel Anderson | Individual | Shares 75–100% | 2017-12-12 | Ceased 2020-04-06 |
Filing timeline
Last 20 of 50 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-03-28 MA Memorandum articles
- 2023-03-28 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-30 | AA | accounts | Accounts with accounts type full | |
| 2025-03-06 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-12-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-05-16 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-16 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-05-16 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-16 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-12-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-09-29 | AA | accounts | Accounts with accounts type total exemption full | |
| 2023-06-07 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2023-06-07 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-03-28 | MA | incorporation | Memorandum articles | |
| 2023-03-28 | RESOLUTIONS | resolution | Resolution | |
| 2023-03-28 | SH10 | capital | Capital variation of rights attached to shares | |
| 2023-03-28 | SH08 | capital | Capital name of class of shares | |
| 2023-02-09 | TM01 | officers | Termination director company with name termination date | |
| 2023-02-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-28 | AA | accounts | Accounts with accounts type total exemption full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.